Although the FDA approved semaglutide for weight loss in 2021, this medications use in treating type 2 diabetes and heart disease dates back to Ozempics2017 approvalfor reducing the risk of heart attack, stroke, or death in people with type 2 diabetes
"Whether its a thyroid issue, a heart condition or another factor slowing your metabolism, any underlying problems should be fixed first." During treatment, Malhotra recommends that her patients come in once a month to make sure they are losing fat and not lean muscle mass
P.SafadiB.SaltiI.NasrallahM
* * Compounded medications may be prescribed based on personal weight loss needs
These innovations are driving the market toward more targeted, effective, and patient-centric weight loss solutions
This is a trust-building scheme